Contact Us

Author: Hakon Agustsson

Cigna Adds Kerecis Intact Fish Skin Grafts to Coverage Policy

CMS Delays Skin Substitute Policy, Intact Fish-Skin Grafts Remain Covered on Existing LCDs

CMS Delays Skin Substitute Policy, Intact Fish-Skin Grafts Remain Covered on Existing LCDs

Kerecis Announces First European Center of Excellence for Medical Fish-Skin Technology

Study Demonstrates Superiority of Kerecis Fish-Skin for Diabetic Foot Ulcer Treatment

Lantis

Kerecis to Present Evidence on Superiority of Fish-Skin Treatment at the Symposium on Advanced Wound Care

Shield Spiral

Kerecis Silicone Fish-Skin Combination for Wound Healing Receives Approval from Palmetto Insurance Group

Shield Spiral

Kerecis Expands Silicone Fish-Skin Combination Product Range with Shield Spiral, Offering Advanced Customizable Wound Care Solutions

Surgibind

Kerecis to Present Scientific and Clinical Updates on Fish-Skin-Grafts at SAWC Spring

Kerecis to Provide Multiple Updates on its Medical-Fish-Skin Technology at EWMA 2024

Export Award

Medical Fish Skin Company Kerecis Receives Export Award from the President of Iceland

Kerecis Nominated as The Life Sciences Company of the Year

Kerecis Vestri

Our Heart Beats With The Local Community

Kerecis Expands Silicone Fish-Skin Combination Product Range

Kerecis Soars to Fourth Place in CSR Survey, Setting New Benchmarks

Isafjordur, Westfjords, Iceland

Kerecis to Attend the J.P. Morgan Healthcare Conference

Kerecis is pioneering the use of fish skin and fatty acids in the globally expanding field of cellular therapy.

Kerecis is part of Coloplast, the leading global supplier of intimate healthcare products.

Products

Company

© 2010 – 2025 Kerecis. All Rights Reserved